{"database": "lobbying", "table": "lobbying_activities", "rows": [[2311969, "6ac1a22d-eac9-4859-b163-89d2ad215a43", "Q2", "BROYDRICK & ASSOCIATES", 7268, "EXELA PHARMA SCIENCES", 2019, "second_quarter", "PHA", "Drug shortages and FDA approval. USTR acceptance.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-07-18T21:31:09.363000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2311969"], "units": {}, "query_ms": 21.37528802268207, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}